Commentary on “Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.” Tsimafeyeu I,Zart JS,Chung B,Kidney Cancer Research Bureau,Moscow, Russian Federation.: BJU Int 2013; 112(1):32–8. [Epub 2013 Jun 7]. doi: 10.1111/bju.12107. |